LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
基本信息
- 批准号:10701231
- 负责人:
- 金额:$ 36.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-15 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAcuteAddressAdultAffectAnimalsAutomobile DrivingBrainBrain InjuriesC-terminalCell Differentiation processCell NucleusCell membraneCellsClinicalCuesDataDefectDiseaseFinding by CauseFutureGenetic TranscriptionGlucoseHomeImpairmentIn VitroInterventionIschemiaIschemic StrokeKnock-outKnockout MiceLDL-Receptor Related Protein 1LaboratoriesLearningLesionLigandsLipoprotein ReceptorMalignant NeoplasmsMeasuresMediatingMembraneMembrane ProteinsMemory impairmentMessenger RNAMethodsMiddle Cerebral Artery OcclusionModelingMusNeurogliaNeurologicOxygenPathway interactionsPatientsProcessProductionProliferatingProtein CProteinsRecoveryRegulationResearchRoleSignal TransductionSignaling ProteinSiteStem cell transplantStrokeSurgical ModelsSurvivorsTertiary Protein StructureTestingTherapeuticTherapeutic EffectTimeTissuesTranscriptional RegulationUnited StatesUp-Regulationbrain repairburden of illnesscell motilitychemokine receptorchromatin immunoprecipitationdeprivationdisabilityexperienceextracellularfunctional disabilityhealingimprovedin vivoinsightischemic lesionmigrationmotor deficitmotor impairmentmotor recoverymouse modelnerve stem cellnestin proteinneuroblastneuroprotectionnew therapeutic targetnewsnovelpost strokeprotein expressionreceptorreceptor bindingred fluorescent proteinrepairedresponseself-renewalstem cell biologystem cell functionstem cell migrationstem cell proliferationstem cell survivalstroke outcomestroke recoverysubventricular zonetherapeutic targettraffickingtranscription factorvirtual
项目摘要
Project Summary/Abstract
The good news is that increasingly, patients who experience an ischemic stroke survive. Unfortunately, survivors
are rarely unscathed — stroke is the leading cause of long-term disability in the U.S. Interventions are limited in
part due to a lack of insight into secondary processes post-stroke. Neural stem cells (NSCs) have demonstrated
therapeutic benefit in stroke recovery. But key questions remain that if answered, could enhance clinical use.
NSCs normally migrate to the lesion, secrete pro-reparative factors, differentiate, and reduce secondary damage.
Central to these benefits is the ability of NSCs to send and respond to specific environmental cues. Our data
show NSC function is influenced by low-density lipoprotein receptor-related protein (LRP1), a multifunctional
receptor that modulates cell signaling via multiple mechanisms. Despite an expansive role in signal modulation,
the importance of LRP1 in NSC biology is virtually unstudied. We knocked-out LRP1 in adult NSCs and subjected
mice to middle-cerebral artery occlusion. We found LRP1-KO in NSCs ablated migration to ischemic lesions.
We also discovered that functional impairment and lesion size were reduced. This observation is somewhat
paradoxical-physical localization of NSCs to lesions is often considered important to neuroprotective efficacy.
We also found that LRP1-KO ablates expression of CXCR4, a chemokine receptor which is essential for
migration to ischemic lesions. Thus, we seek to better understand how impaired LRP1 expression in NSCs is
neuroprotective, and similarly to understand the mechanisms underlying LRP1 regulation of CXCR4. Our overall
hypothesis is that LRP1 promotes NSC migration toward ischemic lesions through CXCR4 regulation,
yet also limits the endogenous NSC-neuroprotective response. Our data suggest that LRP1 is a major driver
of NSC response to signals. This proposal investigates LRP1, CXCR4, and NSC function in stroke using surgical
models, in vivo, and in vitro approaches. We utilize a Nestin-CreERt2 mouse model to direct knock-out of LRP1
and/or CXCR4 in NSCs and to track these cells with expression of red fluorescent protein. Aim 1 tests the
hypothesis that NSC-mediated neuroprotection is due to loss of LRP1, which promotes recovery
independent of effects on CXCR4 by measuring post-stroke outcomes after rescuing expression of CXCR4 in
mice with LRP1-KO in NSCs, or ablating LRP1 in mice with CXCR4-KO in NSCs. Aim 2 tests the hypothesis
that loss of LRP1 (or CXCR4) is neuroprotective by enhancing post-stroke NSC neuroprotective
response by interrogating the effect on NSC post-stroke response and survival, both in vivo and in vitro. Aim 3
tests the mechanism by which LRP1 regulates CXCR4 expression by rescuing LRP1 with domain-specific
constructs and elucidating the effect on transcription, signaling, trafficking, and degradation of CXCR4. Data
from these studies will define the value of NSC-LRP1 as a therapeutic target, identify discrete mechanisms of
LRP1-mediated neuroprotection, and define the mechanism by which LRP1 regulates CXCR4 expression.
项目摘要/摘要
好消息是,经历缺血性中风的患者越来越生存。不幸的是,幸存者
很少毫发无损 - 中风是美国长期残疾的主要原因。
部分是由于对中风后对次要过程缺乏见解。神经干细胞(NSC)已证明
中风恢复中的治疗益处。但是,如果回答得出的话,仍然可以增强临床用途。
NSC通常会迁移到病变,秘密促贡献因素,区分和减少次要损害。
这些好处的核心是NSC发送和响应特定环境线索的能力。我们的数据
显示NSC功能受低密度脂蛋白受体相关蛋白(LRP1)的影响,一种多功能
接收器通过多种机制调节细胞信号。尽管在信号调制中发挥了额外的作用,但
LRP1在NSC生物学中的重要性几乎没有研究。我们在成人NSC中敲出了LRP1,并受到了
小鼠到中脑动脉阻塞。我们在NSC的消融迁移到缺血性病变中发现了LRP1-KO。
我们还发现功能障碍和病变大小降低。这个观察有点
NSC在病变上的矛盾的物理定位通常被认为对神经保护效率很重要。
我们还发现,LRP1-KO消融了CXCR4的表达,CXCR4是一种趋化因子接收器,对
迁移到缺血性病变。那就是,我们试图更好地了解NSC中LRP1表达的受损是如何
神经保护性,类似地了解CXCR4的LRP1调节机制。我们的整体
假设是LRP1通过CXCR4调节促进NSC迁移到缺血性病变,
但也限制了内源性NSC神经保护反应。我们的数据表明LRP1是主要驱动程序
NSC对信号的响应。该提案研究了使用手术的LRP1,CXCR4和NSC功能
模型,体内和体外方法。我们利用Nestin-Creert2鼠标模型直接敲除LRP1
和/或CXCR4在NSC中,并以红色荧光蛋白的表达跟踪这些细胞。 AIM 1测试
NSC介导的神经保护是由于LRP1的丧失引起的,该假设促进了恢复
通过测量在挽救CXCR4表达后的势后结果,独立于对CXCR4的影响
NSC中使用LRP1-KO的小鼠,或在NSC中用CXCR4-KO烧杯LRP1。 AIM 2检验假设
LRP1(或CXCR4)的损失是通过增强中风后NSC神经保护作用的神经保护性的
通过在体内和体外询问对NSC势后反应和生存的影响的反应。目标3
测试LRP1通过用特定域特异性挽救LRP1来调节CXCR4表达的机制
构建并阐明CXCR4的转录,信号传导,运输和降解的影响。数据
从这些研究中将定义NSC-LRP1作为治疗靶标的价值,确定离散机制
LRP1介导的神经保护作用,并定义LRP1调节CXCR4表达的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Naomi Ledene Sayre其他文献
Naomi Ledene Sayre的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Naomi Ledene Sayre', 18)}}的其他基金
The influence of ApoE4 on signaling & poor outcome after traumatic brain injury
ApoE4 对信号传导的影响
- 批准号:
10266025 - 财政年份:2017
- 资助金额:
$ 36.74万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别:
Mechanisms of Cardiac Injury Resolution by CX3CR1+ Macrophages
CX3CR1巨噬细胞解决心脏损伤的机制
- 批准号:
10719459 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别:
Investigating cerebrovascular dysfunction and cerebral atrophy in severe traumatic brain injury
严重颅脑损伤中脑血管功能障碍和脑萎缩的调查
- 批准号:
10742569 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别:
Neural pathways for obesity development by AgRP neurons
AgRP 神经元导致肥胖发展的神经通路
- 批准号:
10681993 - 财政年份:2023
- 资助金额:
$ 36.74万 - 项目类别: